Skip to main content

From The Newsrooms

Officials from Massachusetts discuss the development of best practices for documentation and measurement to support post-overdose outreach programs, an increasingly popular concept across the U.S.
Mood changes and “brain fog” experienced during COVID-19 illness and recovery may stem in part from blood vessel damage and impaired oxygen delivery caused by the disease, suggests a review published in Physiological Reports.
Joseph F. Goldberg, MD, explains why is it important for clinicians treating bipolar disorder to consider both moderators and mediators of treatment outcomes.
Lucy Cannon, EdD, LCSW, LICSW, CCDP-D, MATS, discusses what’s causing a rise in stimulant use among African Americans and how providers can create a more inclusive environment for treatment.
In this video, Psych Congress Steering Committee member Vladimir Maletic, MD, MS, answers the question "How do psychiatric comorbidities affect the mortality risk of people with ADHD?"
The anticonvulsant ezogabine, also known as retigabine, may offer a new approach to the treatment of depression and anhedonia, suggests a trial published online ahead of print in The American Journal of Psychiatry.
Co-occurrence of adult bipolar disorder (BD) and attention/deficit-hyperactivity disorder (ADHD) is heterogenous and “much higher than expected by chance,” according to a meta-analysis published online in Neuroscience & Biobehavioral Reviews.
Mental health clinicians have utilized telehealth to provide treatment throughout the COVID-19 pandemic, creating a need for alternative plans when technology fails and open conversations with patients to remain effective.
Utilizing technology for telehealth treatment and being unable to meet with patients in person has led many mental health clinicians to experience burnout, causing some of them to stop applying best practices and self-care techniques.
Allison Smith, PhD, senior program administrator for the Louisiana Board of Regents, discusses groups within college populations facing a heightened risk of opioid overdose, crafting policy around naloxone administration, and working with university leaders to make colleges safer.
Back to Top